Edmund V. Price
Janssen (United States)(US)
Publications by Year
Research Areas
Computational Drug Discovery Methods, Cancer therapeutics and mechanisms, Protein Tyrosine Phosphatases, Cancer, Hypoxia, and Metabolism, Bioinformatics and Genomic Networks
Most-Cited Works
- → Correlating chemical sensitivity and basal gene expression reveals mechanism of action(2015)969 cited
- → Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases(2016)909 cited
- → Harnessing Connectivity in a Large-Scale Small-Molecule Sensitivity Dataset(2015)868 cited
- → An Interactive Resource to Identify Cancer Genetic and Lineage Dependencies Targeted by Small Molecules(2013)861 cited
- → Dual Allosteric Inhibition of SHP2 Phosphatase(2018)127 cited
- → Identification of Natural Products That Inhibit the Catalytic Function of Human Tyrosyl-DNA Phosphodiesterase (TDP1)(2017)21 cited
- → Recifin A, Initial Example of the Tyr-Lock Peptide Structural Family, Is a Selective Allosteric Inhibitor of Tyrosyl-DNA Phosphodiesterase I(2020)18 cited
- → Identification of small-molecule protein–protein interaction inhibitors for NKG2D(2023)11 cited
- → Biochemical Characterization of Respiratory Syncytial Virus RNA-Dependent RNA Polymerase Complex(2020)6 cited
- → Abstract 2808: Simultaneous inhibition of SHP2 phosphatase at two allosteric sites(2018)1 cited